These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5968462)

  • 21. Reference drug pricing.
    Schneeweiss S; Soumerai SB; Maclure M
    CMAJ; 2002 Jul; 167(2):126-7; author reply 127-8. PubMed ID: 12160115
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug prices bellwether of general inflation.
    Hosp Purch Manage; 1978 Aug; 3(8):6-7. PubMed ID: 10316636
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug prices follow divergent trends.
    Hosp Purch Manage; 1978 Feb; 3(2):8. PubMed ID: 10316562
    [No Abstract]   [Full Text] [Related]  

  • 26. Fixed budgets as a cost containment measure for pharmaceuticals.
    Granlund D; Rudholm N; Wikström M
    Eur J Health Econ; 2006 Mar; 7(1):37-45. PubMed ID: 16435117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manufacturers hike brand-name prices as specialty drug competition increases.
    Hosp Mater Manage; 1988 Feb; 13(2):9. PubMed ID: 10318032
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug prices trend continues tranquil.
    Hosp Purch Manage; 1978 May; 3(5):6-7. PubMed ID: 10316635
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug purchasing.
    Mehl B
    Hosp Pharm; 1988 Mar; 23(3):283-6. PubMed ID: 10318047
    [No Abstract]   [Full Text] [Related]  

  • 30. Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002.
    Andersson K; Petzold MG; Sonesson C; Lönnroth K; Carlsten A
    Health Policy; 2006 Dec; 79(2-3):231-43. PubMed ID: 16473436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMS updates HMM's pharmacy indexes.
    Doyle JJ
    Hosp Mater Manage; 1991 Jan; 16(1):19-22. PubMed ID: 10170632
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug prices continue to be relative bargains in inflation-ridden economy.
    Hosp Purch Manage; 1979 Feb; 4(2):12-3. PubMed ID: 10316767
    [No Abstract]   [Full Text] [Related]  

  • 33. Are generics a drug on the market?
    Tyler VE
    J Indiana State Med Assoc; 1980 Jul; 73(7):452-7. PubMed ID: 7452036
    [No Abstract]   [Full Text] [Related]  

  • 34. THE ECONOMICS OF ADVERSE DRUG REACTIONS--case studies.
    Visconti JA; Smith MC
    Ann Pharmacother; 2006 Mar; 40(3):529-36. PubMed ID: 16507611
    [No Abstract]   [Full Text] [Related]  

  • 35. Hospital pharmacy symposium on new concepts in parenteral drug delivery.
    Anderson RW; Cohen JE; Cohen MR; Kleinberg ML; Lewis GR; McAllister JC; Turco SJ
    Hosp Pharm; 1986 Nov; 21(11):1033-6, 1043-6, 1052-5. PubMed ID: 10317801
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetes: the cost of illness in Sweden.
    Henriksson F; Jönsson B
    J Intern Med; 1998 Dec; 244(6):461-8. PubMed ID: 9893099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional variations and determinants of direct psychiatric costs in Sweden.
    Tiainen A; Edman G; Flyckt L; Tomson G; Rehnberg C
    Scand J Public Health; 2008 Jul; 36(5):483-92. PubMed ID: 18635731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital drug prices rise less than 5% per year.
    Hosp Purch Manage; 1979 May; 4(5):10-1. PubMed ID: 10316803
    [No Abstract]   [Full Text] [Related]  

  • 39. Reflections on a month in the life of the Ontario Drug Benefit Plan.
    McIsaac W; Naylor CD; Anderson GM; O'Brien BJ
    CMAJ; 1994 Feb; 150(4):473-7. PubMed ID: 8313259
    [No Abstract]   [Full Text] [Related]  

  • 40. [Economic aspects of the long-term development of a variety of drugs in Czechoslovakia].
    Federmann J; Honzáková L
    Cesk Zdrav; 1981 May; 29(5):212-8. PubMed ID: 7249130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.